Kevin Dennis Green, the Chief Financial Officer of $CERS, sold 33,676 shares of the company on 06-30-2026 for an estimated $99,105. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares of this class of stock. Following this trade, they now own 1,062,188 shares of this class of $CERS stock.
$CERS Insider Trading Activity
$CERS insiders have traded $CERS stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CERS stock by insiders over the last 6 months:
- WILLIAM MARINER GREENMAN (President and CEO) has made 0 purchases and 3 sales selling 627,863 shares for an estimated $1,198,764.
- VIVEK K JAYARAMAN (Chief Operating Officer) has made 0 purchases and 5 sales selling 274,987 shares for an estimated $566,805.
- KEVIN DENNIS GREEN (Chief Financial Officer) has made 0 purchases and 4 sales selling 244,241 shares for an estimated $480,117.
- RICHARD J BENJAMIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 227,634 shares for an estimated $419,541.
- CHRYSTAL JENSEN (Chief Legal Officer) has made 0 purchases and 2 sales selling 55,174 shares for an estimated $133,457.
- ERIC BJERKHOLT sold 20,454 shares for an estimated $53,180
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CERS Hedge Fund Activity
We have seen 74 institutional investors add shares of $CERS stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 6,753,700 shares (+168.8%) to their portfolio in Q1 2026, for an estimated $12,291,734
- MORGAN STANLEY removed 1,114,173 shares (-57.4%) from their portfolio in Q1 2026, for an estimated $2,027,794
- DRIEHAUS CAPITAL MANAGEMENT LLC added 961,606 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,750,122
- UBS GROUP AG added 956,851 shares (+83.8%) to their portfolio in Q1 2026, for an estimated $1,741,468
- CITADEL ADVISORS LLC removed 945,020 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,719,936
- TWO SIGMA INVESTMENTS, LP added 887,911 shares (+47.8%) to their portfolio in Q1 2026, for an estimated $1,615,998
- BARCLAYS PLC removed 619,762 shares (-69.6%) from their portfolio in Q1 2026, for an estimated $1,127,966
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CERS Revenue
$CERS had revenues of $59.9M in Q1 2026. This is an increase of 22.6% from the same period in the prior year.
You can track CERS financials on Quiver Quantitative's CERS stock page.
You can access data on CERS stock through the Quiver Quantitative API.
$CERS Analyst Ratings
Wall Street analysts have issued reports on $CERS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for $CERS, check out Quiver Quantitative's $CERS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
